Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alicia Fajardo Lubian

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 6, 2023
Use of Bacteriophages to Target Intracellular PathogensAlicia Fajardo-Lubian, Carola Venturini
Antimicrobial Agents and Chemotherapy|November 10, 2020
Effects of Antibiotic Treatment with Piperacillin/Tazobactam versus Ceftriaxone on the Composition of the Murine Gut MicrobiotaCarola Venturini, Bethany Bowring, Alicia Fajardo-Lubian, et al.
EMBO Molecular Medicine|May 27, 2022
Biological foundations of successful bacteriophage therapyCarola Venturini, Aleksandra Petrovic Fabijan, Alicia Fajardo Lubian, et al.
Communicable Diseases Intelligence (2018)|November 17, 2025
Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Surveillance Outcome Program (GnSOP) Bloodstream Infection Annual Report 2024Jan Bell, Alicia Fajardo Lubian, Sally Partridge, et al.
Communicable Diseases Intelligence (2018)|October 21, 2020
Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme (GNSOP) Annual Report 2019Jan M Bell, Alicia Fajardo Lubian, Sally Partridge, et al.
Communicable Diseases Intelligence (2018)|April 6, 2022
Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme (GnSOP) Annual Report 2020Jan M Bell, Alicia Fajardo Lubian, Sally R Partridge, et al.
European Journal of Immunology|March 12, 2025
Differences in Phage Recognition and Immunogenicity Contribute to Divergent Human Immune Responses to Escherichia coli and Klebsiella pneumoniae PhagesHuu Thanh Le, Carola Venturini, Alicia Fajardo Lubian, et al.
Gut Microbes|March 22, 2024
Using a human colonoid-derived monolayer to study bacteriophage translocationHuu Thanh Le, Alicia Fajardo Lubian, Bethany Bowring, et al.
Communicable Diseases Intelligence (2018)|November 15, 2023
Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Surveillance Outcome Program (GnSOP) Bloodstream Infection Annual Report 2022Jan M Bell, Alicia Fajardo Lubian, Sally R Partridge, et al.
Communicable Diseases Intelligence (2018)|November 17, 2022
Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Surveillance Outcome Program (GnSOP)Jan M Bell, Alicia Fajardo Lubian, Sally R Partridge, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 6, 2023
Use of Bacteriophages to Target Intracellular PathogensAlicia Fajardo-Lubian, Carola Venturini
Antimicrobial Agents and Chemotherapy|November 10, 2020
Effects of Antibiotic Treatment with Piperacillin/Tazobactam versus Ceftriaxone on the Composition of the Murine Gut MicrobiotaCarola Venturini, Bethany Bowring, Alicia Fajardo-Lubian, et al.
EMBO Molecular Medicine|May 27, 2022
Biological foundations of successful bacteriophage therapyCarola Venturini, Aleksandra Petrovic Fabijan, Alicia Fajardo Lubian, et al.
Communicable Diseases Intelligence (2018)|November 17, 2025
Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Surveillance Outcome Program (GnSOP) Bloodstream Infection Annual Report 2024Jan Bell, Alicia Fajardo Lubian, Sally Partridge, et al.
Communicable Diseases Intelligence (2018)|October 21, 2020
Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme (GNSOP) Annual Report 2019Jan M Bell, Alicia Fajardo Lubian, Sally Partridge, et al.
Communicable Diseases Intelligence (2018)|April 6, 2022
Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme (GnSOP) Annual Report 2020Jan M Bell, Alicia Fajardo Lubian, Sally R Partridge, et al.
European Journal of Immunology|March 12, 2025
Differences in Phage Recognition and Immunogenicity Contribute to Divergent Human Immune Responses to Escherichia coli and Klebsiella pneumoniae PhagesHuu Thanh Le, Carola Venturini, Alicia Fajardo Lubian, et al.
Gut Microbes|March 22, 2024
Using a human colonoid-derived monolayer to study bacteriophage translocationHuu Thanh Le, Alicia Fajardo Lubian, Bethany Bowring, et al.
Communicable Diseases Intelligence (2018)|November 15, 2023
Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Surveillance Outcome Program (GnSOP) Bloodstream Infection Annual Report 2022Jan M Bell, Alicia Fajardo Lubian, Sally R Partridge, et al.
Communicable Diseases Intelligence (2018)|November 17, 2022
Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Surveillance Outcome Program (GnSOP)Jan M Bell, Alicia Fajardo Lubian, Sally R Partridge, et al.
Pageof 2